(GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families

Neuromuscul Disord. 2005 Feb;15(2):185-90. doi: 10.1016/j.nmd.2004.10.012. Epub 2005 Jan 11.

Abstract

The dominant oculo-pharyngeal muscular dystrophy mutation consists of an expanded (GCN)(12-17) in the coding region of the PolyA Binding Protein Nuclear 1 gene. A founder effect has been demonstrated in Canadian and Bukhara Jewish populations with relatively high prevalence of this disease. Since the oculo-pharyngeal muscular dystrophy prevalence was remarkably high in Southern Uruguay, a founder effect was hypothesized. To identify the ancestral haplotype we determined the (GCN) repeat number and the variants of four intragenic SNPs in Uruguayan OPMD families and a control sample. All families carrying the mutation (GCG)(11)(GCA)(3)(GCG) shared a common ancestral haplotype and the age of the mutation was estimated in 37-53 generations by a composite likelihood method. One family carrying the (GCG)(9)(GCA)(3)(GCG) allele had a different haplotype. The genealogical and molecular data suggested that the common ancestors were Canary Islands' settlers that arrived in Uruguay in the XIX century.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Mutational Analysis
  • Family Health
  • Female
  • Founder Effect*
  • Genealogy and Heraldry
  • Genetic Testing
  • Haplotypes
  • Heterozygote
  • Humans
  • Male
  • Muscular Dystrophy, Oculopharyngeal / genetics*
  • Muscular Dystrophy, Oculopharyngeal / metabolism
  • Muscular Dystrophy, Oculopharyngeal / physiopathology
  • Mutation / genetics*
  • Pedigree
  • Phenotype
  • Poly(A)-Binding Protein II / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • Trinucleotide Repeat Expansion / genetics*
  • Uruguay

Substances

  • Poly(A)-Binding Protein II